FDA, industry preaching opposing CBD narratives on Capitol Hill
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).
Source: naturalproductsinsider.com
Stay updated with breaking news from Radical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).